Pediatric anti N-methyl-D-aspartate receptor encephalitis: a case report
DOI:
https://doi.org/10.18203/2320-6012.ijrms20243739Keywords:
Encephalitis, Autoimmune, NMDA, Immunotherapy, IVIg, Cancer, Paraneoplastic, Psychiatric manifestationAbstract
Anti-N-methyl-D-aspartate receptor encephalitis (NMDARe) is a form of autoimmune encephalitis commonly associated internal malignancy. In this report, we present the case of a 6 years girl with acute onset of left partial seizures rapidly progressed to status epilepticus. The patient had recurrent generalized convulsions requiring multiple admissions. She had dominant neuropsychiatric manifestations, polymorphic seizures, agglomeration of movement disorders and cognitive decline. She did not respond to intravenous steroids and immunoglobulins. She responded to rituximab. She was on maintained on azathioprine for eight months and stopped. Presently she is on two anti-epileptic agents and seizure free. She returned back to school with reasonably good scholastic performance. Early detection, immunomodulation and regular follow up gives good long-term outcomes.
Metrics
References
Graus F, Vogrig A, Muñiz-Castrillo S, Antoine JG, Desestret V, Dubey D, et al. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes. Neurol Neuroimmunol Neuroinflamm. 2021;8(4):1-12.
Nishida H, Kohyama K, Kumada S, Takanashi J, Okumura A, Horino A, et al. Evaluation of the Diagnostic Criteria for Anti-NMDA Receptor Encephalitis in Japanese Children. Neurology. 2021;96(16):e2070-7.
Dalmau J, Graus F. Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease. Lancet Neurol. 2023;22(6):529.
Orozco E, Valencia-Sanchez C, Britton J, Dubey D, Flanagan EP, Lopez-Chiriboga AS, et al. Autoimmune Encephalitis Criteria in Clinical Practice. Neurol Clin Pract. 2023;13:e200151.
Prasad AN, Choudhary S. Intravenous immunoglobulin in pediatrics: A review. Med J Armed Forces India. 2014;70(3):277-80.
Bartolini L. How do you treat anti-NMDA receptor encephalitis? Neurol Clin Pract. 2016;6(1):69-72.
Chiang S, Garg T, Hu A, Amin H, Davalos-Balderas A, Alfradique-Dunham I, et al. Relapse of anti-NMDA receptor encephalitis after prior first- and second-line immunotherapy. Neurology. 2018;90(20):936-9.
Morgan A, Li Y, Thompson NR, Milinovich A, Cohen JA, Ontaneda D, Punia V, et al. Longitudinal Disability, Cognitive Impairment and Mood Symptoms in Patients With Anti-NMDA Receptor Encephalitis. Neurology. 2024;102e(4):1-10.